Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | D Hyman, S Kummar, A Farago, B Geoerger, M Mau-Sorensen, M Taylor, E Garralda, R Nagasubramanian, M Natheson, L Song, M Capra, M Jorgensen, A Ho, N Shukla, S Smith, X Huang, B Tuch, N Ku, TW. Laetsch, A Drilon, D Hong | ||||||||||||
Title | Phase I and expanded access experience of LOXO-195 (BAY 2731954), a selective next-generation TRK inhibitor (TRKi) | ||||||||||||
|
|||||||||||||
URL | https://www.abstractsonline.com/pp8/#!/6812/presentation/9845 | ||||||||||||
Abstract Text | AACR Annual Meeting 2019, Abstract CT127 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|